<i>Listeria monocytogenes</i> Bacteremia During Isatuximab Therapy in a Patient with Multiple Myeloma-Reference-Cited by-同舟云学术

Listeria monocytogenes Bacteremia During Isatuximab Therapy in a Patient with Multiple Myeloma

Published:2021-11-15 Issue:22 Volume:60 Page:3605-3608
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Ueno Toshiyuki¹,Ohta Takanori¹,Imanaga Hiroshi²,Nakazawa Megumi³,Sato Yoriko³,Sugio Yasuhiro¹,Uchida Yujiro³,Ohno Yuju¹,Uehara Yasufumi¹

Affiliation:

1. Department of Hematology, Kitakyushu Municipal Medical Center, Japan

2. Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Japan

3. Department of Infectious Diseases, Kitakyushu Municipal Medical Center, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/60/22/60_7509-21/_pdf

Reference12 articles.

1. 1. Vázquez-Boland JA, Kuhn M, Berche P, et al. Listeria pathogenesis and molecular virulence determinants. Clin Microbiol Rev 14: 584-640, 2001.

2. 2. Shoham S, Bartlett JG. Listeria monocytogenes. Johns Hopkins Medicine POC-IT guides [Internet]. [cited 2021 Feb 27]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540318/all/Listeia_monocytogenes

3. 3. Rivero GA, Torres HA, Rolston KVI, Kontoyiannis DP. Listeria monocytogenes infection in patients with cancer. Diagn Microbiol Infect Dis 47: 393-398, 2003.

4. 4. Lischke T, Heesch K, Schumacher V, et al. CD38 controls the innate immune response against Listeria monocytogenes. Infect Immun 81: 4091-4099, 2013.

5. 5. Maudet C, Levallois S, Disson O, Lecuit M. Innate immune responses to Listeria in vivo. Curr Opin Microbiol 59: 95-101, 2021.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Listeriosis in a Metropolitan Hospital: Is Targeted Therapy a Risk Factor for Infection?;Frontiers in Medicine;2022-04-29

2. Toxicity management strategies for next-generation novel therapeutics in multiple myeloma;Therapeutic Advances in Hematology;2022-01

3. Antineoplastics/cotrimoxazole/unspecified corticosteroid;Reactions Weekly;2021-06